These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 31922157)

  • 1. Glucose-based spiro-oxathiazoles as in vivo anti-hyperglycemic agents through glycogen phosphorylase inhibition.
    Goyard D; Kónya B; Czifrák K; Larini P; Demontrond F; Leroy J; Balzarin S; Tournier M; Tousch D; Petit P; Duret C; Maurel P; Docsa T; Gergely P; Somsák L; Praly JP; Azay-Milhau J; Vidal S
    Org Biomol Chem; 2020 Feb; 18(5):931-940. PubMed ID: 31922157
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose-derived spiro-isoxazolines are anti-hyperglycemic agents against type 2 diabetes through glycogen phosphorylase inhibition.
    Goyard D; Kónya B; Chajistamatiou AS; Chrysina ED; Leroy J; Balzarin S; Tournier M; Tousch D; Petit P; Duret C; Maurel P; Somsák L; Docsa T; Gergely P; Praly JP; Azay-Milhau J; Vidal S
    Eur J Med Chem; 2016 Jan; 108():444-454. PubMed ID: 26708111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel design principle validated: glucopyranosylidene-spiro-oxathiazole as new nanomolar inhibitor of glycogen phosphorylase, potential antidiabetic agent.
    Somsák L; Nagy V; Vidal S; Czifrák K; Berzsényi E; Praly JP
    Bioorg Med Chem Lett; 2008 Oct; 18(20):5680-3. PubMed ID: 18793852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-based spiro-heterocycles as potent inhibitors of glycogen phosphorylase.
    Nagy V; Benltifa M; Vidal S; Berzsényi E; Teilhet C; Czifrák K; Batta G; Docsa T; Gergely P; Somsák L; Praly JP
    Bioorg Med Chem; 2009 Aug; 17(15):5696-707. PubMed ID: 19574053
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucose analog inhibitors of glycogen phosphorylases as potential antidiabetic agents: recent developments.
    Somsák L; Nagya V; Hadady Z; Docsa T; Gergely P
    Curr Pharm Des; 2003; 9(15):1177-89. PubMed ID: 12769745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glycogen phosphorylase in the context of type 2 diabetes, with focus on recent inhibitors bound at the active site.
    Praly JP; Vidal S
    Mini Rev Med Chem; 2010 Oct; 10(12):1102-26. PubMed ID: 20716051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of N-glucopyranosidic derivatives as potential inhibitors that bind at the catalytic site of glycogen phosphorylase.
    Gimisis T
    Mini Rev Med Chem; 2010 Oct; 10(12):1127-38. PubMed ID: 20716054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An assessment of the in vivo efficacy of the glycogen phosphorylase inhibitor GPi688 in rat models of hyperglycaemia.
    Poucher SM; Freeman S; Loxham SJ; Convey G; Bartlett JB; De Schoolmeester J; Teague J; Walker M; Turnbull AV; Charles AD; Carey F; Berg S
    Br J Pharmacol; 2007 Dec; 152(8):1239-47. PubMed ID: 17934512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucopyranosylidene-spiro-imidazolinones, a New Ring System: Synthesis and Evaluation as Glycogen Phosphorylase Inhibitors by Enzyme Kinetics and X-ray Crystallography.
    Szabó KE; Kyriakis E; Psarra AG; Karra AG; Sipos Á; Docsa T; Stravodimos GA; Katsidou E; Skamnaki VT; Liggri PGV; Zographos SE; Mándi A; Király SB; Kurtán T; Leonidas DD; Somsák L
    J Med Chem; 2019 Jul; 62(13):6116-6136. PubMed ID: 31251604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycogen phosphorylase inhibitors: a patent review (2013 - 2015).
    Donnier-Maréchal M; Vidal S
    Expert Opin Ther Pat; 2016; 26(2):199-212. PubMed ID: 26666989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of C-xylopyranosyl- and xylopyranosylidene-spiro-heterocycles as potential inhibitors of glycogen phosphorylase.
    Somsák L; Bokor É; Czibere B; Czifrák K; Koppány C; Kulcsár L; Kun S; Szilágyi E; Tóth M; Docsa T; Gergely P
    Carbohydr Res; 2014 Nov; 399():38-48. PubMed ID: 25081322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of glucose on the potency of two distinct glycogen phosphorylase inhibitors.
    Andersen B; Westergaard N
    Biochem J; 2002 Oct; 367(Pt 2):443-50. PubMed ID: 12099891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, in vitro ADME profiling and in vivo pharmacological evaluation of novel glycogen phosphorylase inhibitors.
    Miao GX; Wang YD; Yan ZW; Zhang LY
    Bioorg Med Chem Lett; 2020 Jul; 30(14):127117. PubMed ID: 32527535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glucopyranosylidene-spiro-benzo[ b][1,4]oxazinones and -benzo[ b][1,4]thiazinones: Synthesis and Investigation of Their Effects on Glycogen Phosphorylase and Plant Growth Inhibition.
    Kun S; Kánya N; Galó N; Páhi A; Mándi A; Kurtán T; Makleit P; Veres S; Sipos Á; Docsa T; Somsák L
    J Agric Food Chem; 2019 Jun; 67(24):6884-6891. PubMed ID: 31135156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of glucopyranosylidene-spiro-thiohydantoin on glycogen metabolism in liver tissues of streptozotocin-induced and obese diabetic rats.
    Docsa T; Czifrák K; Hüse C; Somsák L; Gergely P
    Mol Med Rep; 2011; 4(3):477-81. PubMed ID: 21468595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and evaluation of novel benzazepinone derivatives as glycogen phosphorylase inhibitors with potent activity.
    Wang Y; Yan Z; Guo Y; Zhang L
    Future Med Chem; 2021 May; 13(10):897-909. PubMed ID: 33906369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification, synthesis, and characterization of new glycogen phosphorylase inhibitors binding to the allosteric AMP site.
    Kristiansen M; Andersen B; Iversen LF; Westergaard N
    J Med Chem; 2004 Jul; 47(14):3537-45. PubMed ID: 15214781
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of
    Barr D; Szennyes E; Bokor É; Al-Oanzi ZH; Moffatt C; Kun S; Docsa T; Sipos Á; Davies MP; Mathomes RT; Snape TJ; Agius L; Somsák L; Hayes JM
    ACS Chem Biol; 2019 Jul; 14(7):1460-1470. PubMed ID: 31243960
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the allosteric inhibition of glycogen phosphorylase.
    Loughlin WA
    Mini Rev Med Chem; 2010 Oct; 10(12):1139-55. PubMed ID: 20716052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-based spiro-isoxazolines: a new family of potent glycogen phosphorylase inhibitors.
    Benltifa M; Hayes JM; Vidal S; Gueyrard D; Goekjian PG; Praly JP; Kizilis G; Tiraidis C; Alexacou KM; Chrysina ED; Zographos SE; Leonidas DD; Archontis G; Oikonomakos NG
    Bioorg Med Chem; 2009 Oct; 17(20):7368-80. PubMed ID: 19781947
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.